Literature DB >> 6210828

Human plasmin.

K C Robbins, L Summaria, R C Wohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6210828     DOI： 10.1016/s0076-6879(81)80032-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  10 in total

1.  Identification through combinatorial random and rational mutagenesis of a substrate-interacting exosite in the gamma domain of streptokinase.

Authors:  Suman Yadav; Rachna Aneja; Prakash Kumar; Manish Datt; Sonali Sinha; Girish Sahni
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

2.  Function of the central domain of streptokinase in substrate plasminogen docking and processing revealed by site-directed mutagenesis.

Authors:  A Chaudhary; S Vasudha; K Rajagopal; S S Komath; N Garg; M Yadav; S C Mande; G Sahni
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

3.  Antigenic modification of polioviruses by host proteolytic enzymes.

Authors:  M Roivainen; A Huovilainen; T Hovi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

4.  Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.

Authors:  D Nihalani; G P Raghava; G Sahni
Journal:  Protein Sci       Date:  1997-06       Impact factor: 6.725

5.  Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase.

Authors:  J Wang; E Reich
Journal:  Protein Sci       Date:  1995-09       Impact factor: 6.725

6.  Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.

Authors:  J Reinartz; H Näher; H Mai; M D Kramer
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

7.  Plasminogen activator inhibitor-1: a novel therapeutic target for hypertension?

Authors:  Daniel I Simon; Norman M Simon
Journal:  Circulation       Date:  2013-10-03       Impact factor: 29.690

8.  Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates.

Authors:  M Jauhiainen; J Metso; P Koskinen; C Ehnholm
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

9.  Purification and characterization of mutant miniPlasmin for thrombolytic therapy.

Authors:  Xiaotao Lin; Yan Wang; Yanwen Zhang; Bing Huang; James J Lin; Scott J Hallock; Hong Yu; Hongwei Shao; Jing Yan; Bo Huang; Xuejun C Zhang; Wei Cao; Xueming Xu; Xinli Lin
Journal:  Thromb J       Date:  2013-01-30

10.  ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.

Authors:  Starchild Weivoda; John D Andersen; Aunica Skogen; Patrick M Schlievert; Donna Fontana; Timothy Schacker; Paul Tuite; Janet M Dubinsky; Ronald Jemmerson
Journal:  J Immunol Methods       Date:  2008-04-04       Impact factor: 2.303
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.